Menu

CDC Director Delivers Passionate Speech to Agency

Robert Redfield emphasized the importance of science and data in meeting with employees.

Mar 30, 2018
Jim Daley

JAMES GATHANY, WIKIMEDIA

Robert Redfield, the newly appointed director of the Centers for Disease Control and Prevention (CDC), delivered an emotional address to agency members Thursday (March 29) in which he said he was honored to lead the best “science-based, data-driven agency in the world,” reports the The Washington Post. During his remarks he frequently emphasized the importance of science and data, saying they are the reason for the agency’s credibility. According to the Post, the speech was well received by agency employees.

In January, top CDC officials reportedly instructed employees to avoid using seven words in budget documents, including “evidence-based” and “science-based.” That same month, Brenda Fitzgerald resigned as director of the agency after less than a year in the position because of financial conflicts of interest. Redfield did not address either issue in his remarks.

See “Federal Officials and Scientists Respond to Purported CDC Word Ban

Redfield, who took the helm of the CDC last week, also vowed to bring the opioid crisis “to its knees” (via The Republic). He said the AIDS epidemic could be ended in the U.S. “in the next three to seven years, if we put our mind to it,” according to STAT News.

In the address, Redfield called the opioid epidemic “the public health crisis of our time,” noting it is a medical, not a moral, issue, and saying the CDC would help direct the government’s response, The Washington Post reports. “If any of you have tried to access care for addiction in this nation, I can guarantee you it’s complicated,” he said.

See “AIDS Researcher Emerges as Top Candidate to Head CDC

Reactions to Redfield’s appointment from AIDS activists have been mixed. Sarah Kate Ellis, the president and CEO of the Gay & Lesbian Alliance Against Defamation (GLAAD), says in a March 21 Wall Street Journal article that “HIV advocates have pointed to Redfield’s record of promoting stigma and fear around HIV and AIDS and that should give us pause about this appointment.” In the same article Michael Ruppal, executive director of The AIDS Institute, says Redfield’s appointment “provides us with great optimism.”

In an opinion published March 23 in Foreign Policy, Laurie Garrett, a former Senior Fellow at the Council on Foreign Relations Global Health Program, calls Redfield “exactly the wrong person for the job.” She writes that Redfield’s record in HIV research “has been a scientific and moral failure,” citing his policy that mandated HIV testing for all troops in 1985, while he was a US Army major at the Walter Reed Army Institute of Research. Redfield was also involved in an unsuccessful attempt to require HIV testing of health-care professionals who perform invasive procedures in 1991, according to The Washington Post

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.